DCBT
CPRX

Dakota Community Bank & Trust’s Catalyst Pharmaceutical CPRX Stock Holding History

Dakota Community Bank & Trust’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,740
Closed -$81.2K – 123
2025
Q2 		$81.2K Buy
+3,740
New +$88.3K 0.36% 74

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dakota Community Bank & Trust's CPRX Position: Q3 2025 in Review

Dakota Community Bank & Trust sold out of Catalyst Pharmaceutical (CPRX) in Q3 2025, closing a stake of 3,740 shares — an estimated $81.2K sold.

Dakota Community Bank & Trust first reported a position in CPRX in Q2 2025 and held it in 1 quarter. The position peaked at $81.2K in Q2 2025. 360 funds tracked by Wall St. Rank hold CPRX as of Q3 2025.

  • Dakota Community Bank & Trust reported no remaining Catalyst Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Dakota Community Bank & Trust sold 3,740 Catalyst Pharmaceutical shares in Q3 2025, an estimated $81.2K.
  • Dakota Community Bank & Trust first reported a position in Catalyst Pharmaceutical in Q2 2025 and held it in 1 quarter.
  • Dakota Community Bank & Trust's Catalyst Pharmaceutical position peaked at $81.2K in Q2 2025.
  • 360 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2025.

Based on Dakota Community Bank & Trust's 13F filing for Q3 2025, filed 9 Oct 2025.